My group’s research focuses on developing and implementing advanced quantitative imaging biomarkers derived from MR imaging physics techniques including MR fingerprinting (MRF), diffusion-weighted MRI (DW-MRI), dynamic contrast-enhanced MRI (DCE-MRI), and MR spectroscopy (MRS) for clinical application in cancer.
Amita Shukla Dave, PhD, FISMRM
Director, Quantitative Imaging; Deputy Service Chief Predictive Informatics
Research Focus
Medical physicist Amita Shukla Dave’s clinical and research focus is on the development and implementation of advanced quantitative imaging biomarkers for application in cancer care.- Office Phone: 212-639-3184
Publications
- Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF. Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2019 Jun;49(7):e101-e121
- Paudyal R, Konar AS, Obuchowski NA, Hatzoglou V, Chenevert TL, Malyarenko DI, Swanson SD, LoCastro E, Jambawalikar S, Liu MZ, Schwartz LH, Tuttle RM, Lee N, Shukla-Dave A. Repeatability of Quantitative Diffusion-Weighted Imaging Metrics in Phantoms, Head-and-Neck and Thyroid Cancers: Preliminary Findings. Tomography. 2019 Mar;5(1):15-25